Steve Salzberg laments new evidence indicating that the real number of human genes is just 20,500.
Elizabeth Blackburn sits down for an interview with Discover magazine.
Science research looks at Bt toxins, mammalian Xic, and deubiquitinating enzymes.
Tech Review speaks with George Church.
Jason Bobe blogs on encouraging people's willingness to have their genomes sequenced.
Generosity might be in your genes, says a study from Hebrew University.
The Economist warns consumers that some genetic testing services are less than reputable.
A commentary in the WSJ calls for an emphasis on scientific understanding among US presidential candidates.
For your morning dose of disappointment, here's a sobering look at the pharma industry from the Wall Street Journal.
SNPs and other genetic variation are linked to differing response to antipsychotic drugs in patients with mental illness.
Nature looks in on creative commons licenses for genome papers, German funding increases, type one diabetes, and more.
A supercomputer is good to the environment.
An underfunded FDA puts consumers at risk, a report says.
Open science gains ground through Google Code.
Salon's take on Venter and the rise of the intellectual entrepreneur.
Tech Review covers a new database of organ-specific gene expression patterns linked to aging.
EMBL has a new phylogenetics visualization toy out on the Internet.
A blogger writes about research on sexually antagonistic genes.
A report says that toxins in the water are spurring genetic mutations among Indian people living in the Punjab.
From Wired, articles on California's stem cell agency and new findings from one of the teams that turned a skin cell into what looks like an embryonic stem cell.
Genetic advisors to the British government say genetic testing is "a dangerous waste of money."
Genomeboy attempts to clear up confusion about costs for sequencing genomes and exomes.
The Boston Globe has an article about the war on cancer, saying that despite some progress, there's growing discouragement about emerging victorious.
Novartis and MorphoSys expand a collaboration in a deal valued at $600 million.
At long last, George Church's Personal Genome Project gets a new website. Check out info on the next chance to participate -- enrollment opens in early 2008.
An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.
NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.
At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.
Patricia Fara writes about childcare funding, and women in science and science history at NPR.